These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38058427)

  • 21. A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma.
    Ma C; Li F; Gu Z; Yang Y; Qi Y
    Front Pharmacol; 2023; 14():1146840. PubMed ID: 37670938
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
    Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
    BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a novel 5 cuproptosis-related long noncoding RNA signature to predict diagnosis, prognosis, and drug therapy in clear cell renal cell carcinoma.
    Chen Y; Hu W; Wei X; Zhang L; Shao Y; Tian J; Wang D; Wu B
    Transl Androl Urol; 2023 Apr; 12(4):622-641. PubMed ID: 37181235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and immune microenvironment analysis of cuproptosis-related LncRNAs in breast cancer.
    Pan Y; Zhang Q; Zhang H; Kong F
    Funct Integr Genomics; 2023 Jan; 23(1):38. PubMed ID: 36640225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a cuproptosis and copper metabolism gene-related lncRNAs prognostic signature associated with clinical and immunological characteristics of hepatocellular carcinoma.
    Yuan W; Xiao JH; Zhang JS; Mao BL; Wang PZ; Wang BL
    Front Oncol; 2023; 13():1153353. PubMed ID: 37056336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A signature of cuproptosis-related lncRNAs predicts prognosis and provides basis for future anti-tumor drug development in breast cancer.
    Yu H; Liu Y; Zhang W; Peng Z; Yu X; Jin F
    Transl Cancer Res; 2023 Jun; 12(6):1392-1410. PubMed ID: 37434691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cuproptosis-related lncRNAs risk model to predict prognosis and guide immunotherapy for lung adenocarcinoma.
    Li Q; Wang T; Zhu J; Zhang A; Wu A; Zhou Y; Shi J
    Ann Transl Med; 2023 Mar; 11(5):198. PubMed ID: 37007546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma.
    Wang F; Lin H; Su Q; Li C
    World J Surg Oncol; 2022 Sep; 20(1):275. PubMed ID: 36050740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cuproptosis-related lncRNAs as potential biomarkers of AML prognosis and the role of lncRNA HAGLR/miR-326/CDKN2A regulatory axis in AML.
    Du A; Yang Q; Luo X
    Am J Cancer Res; 2023; 13(9):3921-3940. PubMed ID: 37818049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signature of seven cuproptosis-related lncRNAs as a novel biomarker to predict prognosis and therapeutic response in cervical cancer.
    Liu X; Zhou L; Gao M; Dong S; Hu Y; Hu C
    Front Genet; 2022; 13():989646. PubMed ID: 36204323
    [No Abstract]   [Full Text] [Related]  

  • 31. Construction of an endoplasmic reticulum stress and cuproptosis -related lncRNAs signature in chemosensitivity in hepatocellular carcinoma by comprehensive bioinformatics analysis.
    Qi XL; Luo GQ; Tuersun A; Chen M; Wu GB; Zheng L; Li HJ; Lou XL; Luo M
    Heliyon; 2024 Oct; 10(19):e38342. PubMed ID: 39398070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma.
    Zhang L; Di L; Liu J; Lei X; Gu M; Zhang W; Wang Y
    Front Genet; 2023; 14():1039813. PubMed ID: 36755568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiosensitization-Related Cuproptosis LncRNA Signature in Non-Small Cell Lung Cancer.
    Xu Q; Liu T; Wang J
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer.
    Bai Y; Zhang Q; Liu F; Quan J
    Front Immunol; 2022; 13():1027449. PubMed ID: 36451815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
    Song Y; Qu H
    BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and verification of a newly established cuproptosis-associated lncRNA model for predicting overall survival in uterine corpus endometrial carcinoma.
    Hu P; Wang Y; Chen X; Zhao L; Qi C; Jiang G
    Transl Cancer Res; 2023 Aug; 12(8):1963-1979. PubMed ID: 37701111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive analysis of cuproptosis-related lncRNAs to predict prognosis and immune infiltration characteristics in colorectal cancer.
    Zhu Z; Zhao Q; Li S; Weng J; Guo T; Zhu C; Xu Y
    Front Genet; 2022; 13():984743. PubMed ID: 36467996
    [No Abstract]   [Full Text] [Related]  

  • 38. Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer.
    Pang L; Wang Q; Wang L; Hu Z; Yang C; Li Y; Wang Z; Li Y
    BMC Med Genomics; 2023 Mar; 16(1):58. PubMed ID: 36949429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and Evaluation of a Novel Cuproptosis-Related lncRNA Signature for Gastric Cancer Prognosis.
    Yin C; Gao M; Wang Q; Li H
    Comput Math Methods Med; 2023; 2023():6354212. PubMed ID: 36820319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer.
    Xu QT; Wang ZW; Cai MY; Wei JF; Ding Q
    Front Pharmacol; 2022; 13():1115608. PubMed ID: 36699089
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.